ADP-ribosylarginine hydrolase regulates cell proliferation and tumorigenesis

Cancer Research

Volumn 71, Issue 15, 2011, Pages 5327-5335

  Kato, Jiro ^a   Zhu, Jianfeng ^a   Liu, Chengyu ^a   Stylianou, Mario ^a   Hoffmann, Victoria ^b   Lizak, Martin J ^b   Glasgow, Connie G ^a   Moss, Joel ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; ADENOSINE DIPHOSPHATE RIBOSYLARGININE HYDROLASE; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; CULTURE MEDIUM; EXON; FEMALE; GENE FUNCTION; GENE MUTATION; GENOTYPE; HEMANGIOMA; HETEROZYGOSITY LOSS; LIVER CELL CARCINOMA; LYMPHOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PROCESSING; RHABDOMYOSARCOMA; SARCOMA;

ADENOSINE DIPHOSPHATE RIBOSE; ANIMALS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; LOSS OF HETEROZYGOSITY; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE; N-GLYCOSYL HYDROLASES; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; PROTEIN PROCESSING, POST-TRANSLATIONAL; TUMOR STEM CELL ASSAY;

EID: 79960958113     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-0733     Document Type: Article

References (37)

1. Williamson KC, Moss J. Mono-ADP-ribosyltransferases and ADPribosylarginine hydrolase: a mono-ADP-ribosylation cycle in animal cells. In: Moss J, Vaughan M, editors. ADP-ribosylating toxins and G proteins: insights into signal transduction. Washington, D.C.: ASM Press; 1990. p. 493-510.
2. Okazaki IJ, Moss J. Characterization of glycosylphosphatidylinositiol- anchored, secreted, and intracellular vertebrate mono-ADP-ribosyltransferases. Annu Rev Nutr 1999;19:485-509. (Pubitemid 29380614)
3. Corda D, Di Girolamo M. Functional aspects of protein mono-ADP-ribosylation. EMBO J 2003;22:1953-8. (Pubitemid 36565521)
4. Moss J, Vaughan M. ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins. Adv Enzymol Relat Areas Mol Biol 1988;61:303-79.
5. Ui M. Pertussis toxin as a valuable probe for G-protein involvement in signal transduction. In: Moss J, Vaughan M, editors. ADP-ribosylating toxins and G proteins: insights into signal transduction. Washington, D.C.: ASM Press; 1990. p. 45-77.
6. Okazaki IJ, Moss J. Glycosylphosphatidylinositol-anchored and secretory isoforms of mono-ADP-ribosyltransferases. J Biol Chem 1998;273:23617-20.
7. Okazaki IJ, Moss J. Structure and function of eukaryotic mono-ADP-ribosyltransferases. Rev Physiol Biochem Pharmacol 1996;129: 51-104.
8. Moss J, Stanley SJ, Oppenheimer NJ. Substrate specificity and partial purification of a stereospecific NAD- and guanidine-dependent ADP-ribosyltransferase from avian erythrocytes. J Biol Chem 1979;254: 8891-4.
9. Paone G, Wada A, Stevens LA, Matin A, Hirayama T, Levine RL, et al. ADP ribosylation of human neutrophil peptide-1 regulates its biological properties. Proc Natl Acad Sci U S A 2002;99:8231-5. (Pubitemid 34651035)
10. Paone G, Stevens LA, Levine RL, Bourgeois C, Steagall WK, Gochuico BR, et al. ADP-ribosyltransferase-specific modification of human neutrophil peptide-1. J Biol Chem 2006;281:17054-60.
11. Stevens LA, Levine RL, Gochuico BR, Moss J. ADP-ribosylation of human defensin HNP-1 results in the replacement of the modified arginine with the noncoded amino acid ornithine. Proc Natl Acad Sci U S A 2009; 106:19796-800.
12. Zolkiewska A, Moss J. Processing of ADP-ribosylated integrin alpha 7 in skeletal muscle myotubes. J Biol Chem 1995;270:9227-33.
13. Zolkiewska A, Moss J. Integrin alpha 7 as substrate for a glycosylphosphatidylinositol- anchored ADP-ribosyltransferase on the surface of skeletal muscle cells. J Biol Chem 1993;268:25273-6.
14. Zolkiewska A, Nightingale MS, Moss J. Molecular characterization of NAD:arginine ADP-ribosyltransferase from rabbit skeletal muscle. Proc Natl Acad Sci U S A 1992;89:11352-6.
15. Wang J, Nemoto E, Kots AY, Kaslow HR, Dennert G. Regulation of cytotoxic T cells by ecto-nicotinamide adenine dinucleotide (NAD) correlates with cell surface GPI-anchored/arginine ADP-ribosyltransferase. J Immunol 1994;153:4048-58.
16. Wang J, Nemoto E, Dennert G. Regulation of CTL by ecto-nictinamide adenine dinucleotide (NAD) involves ADP-ribosylation of a p56lck-associated protein. J Immunol 1996;156:2819-27.
17. Moss J, Jacobson MK, Stanley SJ. Reversibility of arginine-specific mono(ADP-ribosyl)ation: identification in erythrocytes of an ADP-ribose- L-arginine cleavage enzyme. Proc Natl Acad Sci U S A 1985;82:5603-7. (Pubitemid 16218813)
18. Moss J, Oppenheimer NJ, West RE Jr, Stanley SJ. Amino acid specific ADP-ribosylation: substrate specificity of an ADP-ribosylarginine hydrolase from turkey erythrocytes. Biochemistry 1986;25:5408-14.
19. Moss J, Stanley SJ, Nightingale MS, Murtagh JJ Jr, Monaco L, Mishima K, et al. Molecular and immunological characterization of ADP-ribosylarginine hydrolases. J Biol Chem 1992;267:10481-8.
20. Lowery RG, Ludden PW. Endogenous ADP-ribosylation in prokaryotes. In: Moss J, Vaughan M, editors. ADP-ribosylating Toxins and G proteins: Insights into Signal Transduction. Washington, D.C.: ASM Press; 1990. p. 459-78.
21. Moss J, Tsai SC, Adamik R, Chen HC, Stanley SJ. Purification and characterization of ADP-ribosylarginine hydrolase from turkey erythrocytes. Biochemistry 1988;27:5819-23.
22. Takada T, Iida K, Moss J. Cloning and site-directed mutagenesis of human ADP-ribosylarginine hydrolase. J Biol Chem 1993;268: 17837-43. (Pubitemid 23260294)
23. Takada T, Iida K, Moss J. Conservation of a common motif in enzymes catalyzing ADP-ribose transfer. Identification of domains in mammalian transferases. J Biol Chem 1995;270:541-4.
24. Konczalik P, Moss J. Identification of critical, conserved vicinal aspartate residues in mammalian and bacterial ADP-ribosylarginine hydrolases. J Biol Chem 1999;274:16736-40.
25. Kato J, Zhu J, Liu C, Moss J. Enhanced sensitivity to cholera toxin in ADP-ribosylarginine hydrolase-deficient mice. Mol Cell Biol 2007;27: 5534-43. (Pubitemid 47124405)
26. Sato JD, Kan M. Growth of transformed cells in soft agar. In: Bonifacino JS, Dasso M, Harford JB, Schwartz JL, Yamada KM, editors. Current protocols in cell biology. Hoboken, NJ: John Wiley &Sons; 1998. p. 1.2.1-1.2.15
27. Hollingshead M. Intraperitoneal and subcutaneous tumor models for assessing anti-neoplastic agents in rodent. In: Enna SJ, Williams M, Ferkany JW, Frechette R, Kenakin T, Moser P, Ruggeri B, editors. Current protocols in Pharmacology. Hoboken, NJ: John Wiley &Sons; 2002. p. 5.28.1-5.28.13.
28. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994;266:1821-28.
29. Kohn KW, Jackman J, O'Conner PM. Cell cycle control and cancer chemotherapy. J Cell Biochem 1994;54:440-52. (Pubitemid 24131349)
30. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci U S A 1992;89:7491-95.
31. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the celluar response to DNA damage. Cancer Res 1991;51:6304-11.
32. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992;356:215-21.
33. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994;4:1-7.
34. Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 2004;4:793-805. (Pubitemid 39331151)
35. Myatt SS, Lam EW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 2007;7:847-59. (Pubitemid 350006253)
36. Karnoub AE, Weinberg RA. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 2008;9:517-31. (Pubitemid 351881844)
37. Miwa M, Masutani M. PolyADP-ribosylation and cancer. Cancer Sci 2007;98:1528-35. (Pubitemid 47308446)